ABL Bio, Inc. financial statements
ABL Bio, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | KRW 79.35B | EODHD |
| Net income | −KRW 37.81B | EODHD |
| Cash and equivalents | KRW 111.98B | EODHD |